Wang Z - Search Results

1

High Expression of microRNA-223 Indicates a Good Prognosis in Triple-Negative Breast Cancer.

Chen L, Zhu X, Han B, Ji L, Yao L, Wang Z. Chen L, et al. Among authors: wang z. Front Oncol. 2021 Apr 13;11:630432. doi: 10.3389/fonc.2021.630432. eCollection 2021. Front Oncol. 2021. PMID: 33928027 Free PMC article.

2

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial.

Hu XC, Zhang J, Xu BH, Cai L, Ragaz J, Wang ZH, Wang BY, Teng YE, Tong ZS, Pan YY, Yin YM, Wu CP, Jiang ZF, Wang XJ, Lou GY, Liu DG, Feng JF, Luo JF, Sun K, Gu YJ, Wu J, Shao ZM. Hu XC, et al. Lancet Oncol. 2015 Apr;16(4):436-46. doi: 10.1016/S1470-2045(15)70064-1. Epub 2015 Mar 18. Lancet Oncol. 2015. PMID: 25795409 Clinical Trial.

3

Depletion of SENP1 suppresses the proliferation and invasion of triple-negative breast cancer cells.

Wang Z, Jin J, Zhang J, Wang L, Cao J. Wang Z, et al. Among authors: wang l. Oncol Rep. 2016 Oct;36(4):2071-8. doi: 10.3892/or.2016.5036. Epub 2016 Aug 24. Oncol Rep. 2016. PMID: 27573572

4

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.

Jin J, Gao Y, Zhang J, Wang L, Wang B, Cao J, Shao Z, Wang Z. Jin J, et al. Among authors: wang l, wang z, wang b. BMC Cancer. 2018 Apr 19;18(1):446. doi: 10.1186/s12885-018-4371-0. BMC Cancer. 2018. PMID: 29673325 Free PMC article.

5

Metastatic breast cancer patients with lung or liver metastases should be distinguished before being treated with fulvestrant.

He M, Li JJ, Zuo WJ, Ji L, Jiang YZ, Hu XC, Wang ZH, Shao ZM. He M, et al. Cancer Med. 2019 Oct;8(14):6212-6220. doi: 10.1002/cam4.2453. Epub 2019 Aug 2. Cancer Med. 2019. PMID: 31373147 Free PMC article.

6

The prognostic and predictive potential of Ki-67 in triple-negative breast cancer.

Zhu X, Chen L, Huang B, Wang Y, Ji L, Wu J, Di G, Liu G, Yu K, Shao Z, Wang Z. Zhu X, et al. Among authors: wang z, wang y. Sci Rep. 2020 Jan 14;10(1):225. doi: 10.1038/s41598-019-57094-3. Sci Rep. 2020. PMID: 31937819 Free PMC article.

7

Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations.

Jiang YZ, Ge LP, Jin X, Fan L, He M, Liu Y, Chen L, Zuo WJ, Wu J, Liu GY, Di GH, Wang ZH, Yu KD, Shao ZM. Jiang YZ, et al. Breast Cancer Res Treat. 2021 Jan;185(2):371-380. doi: 10.1007/s10549-020-05940-8. Epub 2020 Sep 25. Breast Cancer Res Treat. 2021. PMID: 32975708 Clinical Trial.

8

A Prognostic Model for Breast Cancer With Liver Metastasis.

Ji L, Fan L, Zhu X, Gao Y, Wang Z. Ji L, et al. Among authors: wang z. Front Oncol. 2020 Sep 2;10:1342. doi: 10.3389/fonc.2020.01342. eCollection 2020. Front Oncol. 2020. PMID: 33014776 Free PMC article.

9

Risk and prognostic factors of breast cancer with liver metastases.

Ji L, Cheng L, Zhu X, Gao Y, Fan L, Wang Z. Ji L, et al. Among authors: wang z. BMC Cancer. 2021 Mar 6;21(1):238. doi: 10.1186/s12885-021-07968-5. BMC Cancer. 2021. PMID: 33676449 Free PMC article.

10

Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer.

Zhu X, Chen L, Huang B, Li X, Yang L, Hu X, Jiang Y, Shao Z, Wang Z. Zhu X, et al. Among authors: wang z. J Exp Clin Cancer Res. 2021 Apr 8;40(1):122. doi: 10.1186/s13046-021-01930-w. J Exp Clin Cancer Res. 2021. PMID: 33832512 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127,169 results

Search Page